STOCK TITAN

HEXO Corp Announces Repayment of Credit Facility

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

OTTAWA, May 03, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that it has repaid, effective April 30, 2021, the total outstanding balance on its credit facility established under its credit agreement dated February 14, ‎‎2019 with Canadian Imperial Bank of Commerce as sole bookrunner, co-lead arranger and administrative agent, and Bank of Montreal as co-lead arranger and syndication agent, together with accrued interest and associated fees, in the ‎amount of approximately $28.9 million.

“We believe repayment of the credit facility provides HEXO with flexibility as we continue to execute on our US expansion plans and our goal to become a top two Canadian LP by adult-use recreational cannabis sales,” said HEXO CEO and co-founder Sebastien St-Louis. “We would like to thank our lenders for their support, which has contributed to HEXO’s success to date.”

About HEXO (TSX: HEXO; NYSE: HEXO)

HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO, HEXO Plus, Up, Original Stash and Bake Sale brands and the medical market under HEXO medical cannabis. For more information, please visit hexocorp.com.

Forward Looking Statements

This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are based on certain expectations and assumptions and are subject to known and unknown risks and uncertainties and other factors that could cause actual events, results, performance and achievements to differ materially from those anticipated in these forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

Investor Relations:

invest@HEXO.com

www.hexocorp.com 

Media Relations:

(819) 317-0526

media@hexo.com


HEXO

NASDAQ:HEXO

HEXO Rankings

HEXO Latest News

HEXO Stock Data

31.24M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Canada
Ottawa

About HEXO

hydropothecary est un producteur agréé et distributeur de marijuana médicale en vertu du règlement sur l'accès aux cannabis pour fins médicales (racfm) de santé canada. nous sommes voués à l’excellence médicale et excellons dans nos techniques de culture, les contrôles des processus, les tests d’assurance-qualité, les activités de recherche et développement et l’offre d’un service à la clientèle exceptionnel. nous sommes fiers de la croissance remarquable de notre entreprise jusqu’à présent et anticipons grandement la continuation de cette expansion avec l’ajout d’une serre de 250 000 pieds carrés supplémentaires en 2018. nous sommes constamment à la recherche de professionnels talentueux, énergiques et hautement spécialisés pour joindre notre équipe et faire partie d'une industrie passionnante en évolution continue. ------------ the hydropothecary is a licensed producer and distributor of medical marijuana under health canada’s access to cannabis for medical purposes regulations (acmp